HIGHLIGHTS
- who: Henry H. Balfour et al. from the Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN, USA have published the research: Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine, in the Journal: Vaccines 2022, 10, 1399. of 14/07/2022
- how: The authors explored feasibility of multicenter EBV vaccine trials on college campuses by collaborating on a cross-sectional EBV antibody study of University of Iowa freshmen from the Class of 2022 .
SUMMARY
Epstein-Barr virus (EBV . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.